|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Products
Gentron A and Peg-Gentron A: Gentron A is a formulated product which contains as its active ingredient, interferon alpha 2b. Peg-Gentron A is a pegylated interferon alpha 2b with an extended half-life. Both products are being developed to treat a number of viral diseases, including hepatitis C, as well as a number of human malignancies.
Syntropin: Syntropin is a formulated product containing human growth hormone as the active pharmaceutical agent. It is being developed to treat those indications approved by the U.S. FDA for human growth hormone therapy.
Beta-interferon is an approved drug used in the treatment of multiple sclerosis. GCSF is a cytokine approved for use in cancer chemotherapy patients who often experience a drop in their white blood cell counts. Phage has manufactured both of these products with pre-clinical testing of the products underway.
Single Chain Antibodies: Therapeutic antibodies enjoy widespread use in the treatment of certain forms of cancer, rheumatoid arthritis and autoimmune diseases. Single chain antibodies, that mimic the action of therapeutic antibodies, can be produced efficiently and inexpensively by the Phage process.
Home | Contact Us |
Webmaster
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||